U.S. Department of Justice Investigation of a State Psychiatric Hospital.


Journal

The journal of the American Academy of Psychiatry and the Law
ISSN: 1943-3662
Titre abrégé: J Am Acad Psychiatry Law
Pays: United States
ID NLM: 9708963

Informations de publication

Date de publication:
09 2023
Historique:
medline: 4 9 2023
pubmed: 18 7 2023
entrez: 17 7 2023
Statut: ppublish

Résumé

The Department of Justice investigation of state psychiatric hospitals is nothing like investigation by more familiar regulatory agencies such as The Joint Commission or Centers for Medicare and Medicaid Services (CMS). For one, it comes with the threat of serious legal consequences for both the state psychiatric hospital under investigation and the state in general. Although little has been written about this topic, much of what has been written describes a negative, painful, and expansive experience affecting every aspect of the hospital system. Using an example of a state psychiatric hospital that has been investigated by the DOJ, this article examines this portrayal and explores whether there are positive aspects of such investigations that have been overlooked.

Identifiants

pubmed: 37460220
pii: JAAPL.230009-23
doi: 10.29158/JAAPL.230009-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-376

Informations de copyright

© 2023 American Academy of Psychiatry and the Law.

Auteurs

Charles C Dike (CC)

Dr. Dike is Associate Professor of Psychiatry, Yale University School of Medicine, New Haven, CT, and Medical Director, Office of the Commissioner, Connecticut Department of Mental Health and Addiction Services, Hartford, CT. Ms. Bugella is CEO, Bugella Behavioral Healthcare Consulting, LLC, Berlin, CT. Dr. Hillbrand is Assistant Clinical Professor of Psychiatry, Yale University School of Medicine, New Haven, CT. Charles.dike@yale.edu.

Barbara A Bugella (BA)

Dr. Dike is Associate Professor of Psychiatry, Yale University School of Medicine, New Haven, CT, and Medical Director, Office of the Commissioner, Connecticut Department of Mental Health and Addiction Services, Hartford, CT. Ms. Bugella is CEO, Bugella Behavioral Healthcare Consulting, LLC, Berlin, CT. Dr. Hillbrand is Assistant Clinical Professor of Psychiatry, Yale University School of Medicine, New Haven, CT.

Marc Hillbrand (M)

Dr. Dike is Associate Professor of Psychiatry, Yale University School of Medicine, New Haven, CT, and Medical Director, Office of the Commissioner, Connecticut Department of Mental Health and Addiction Services, Hartford, CT. Ms. Bugella is CEO, Bugella Behavioral Healthcare Consulting, LLC, Berlin, CT. Dr. Hillbrand is Assistant Clinical Professor of Psychiatry, Yale University School of Medicine, New Haven, CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH